Is Collective Health profitable in 2026?

Collective Health does not publicly disclose audited revenue or profit figures. It remains privately held and has not raised a new priced funding round since its $280M Series F in May 2021, leaving its financial health unverified as of 2026.

Is Collective Health a safe company to join right now?

Collective Health has real product lock-in via 200+ EDI integrations and $25B in processed claims (as of April 2026), but its $1.5B valuation dates to May 2021 with no fresh round since, and it now trails merged rival Transcarent-Accolade's 20M+ members versus its own 800,000.

Who is Collective Health's biggest competitor?

Transcarent completed its merger with Accolade in April 2025, creating a combined entity with 20M+ members and 1,700+ clients, dwarfing Collective Health's 800,000 members reported as of April 2026, making it the primary consolidation threat in benefits navigation.

Has Collective Health had layoffs?

Yes. In February 2023, CEO Ali Diab announced a layoff of 54 employees. No further Collective Health-specific layoffs have been publicly reported since, and headcount has since grown toward 750 to 800 employees per trackers.

What is Collective Health worth and who funds it?

Collective Health was valued at approximately $1.5 billion after its $280M Series F in May 2021, led by Health Care Service Corporation with DFJ Growth, Founders Fund, and SoftBank Vision Fund participating. No new priced round has been reported since.

How many members does Collective Health serve compared to rivals?

Collective Health reports 800,000+ members across 50 states as of April 2026, up from 300,000 in 2021, but rival Transcarent-Accolade reached 20M+ members after their April 2025 merger, a scale gap of roughly 25x.

United States · United States

Collective Health

Runs claims and navigation software for employers who self-fund health benefits.

Losing its protection

Assessed 29 July 2026 · Evidence as of 29 July 2026

The structural protection is eroding.

On the recordSince 29 July 2026 · Checkable from unclear, watch through 2026 · Every call on the record Checkpoint: Any fresh priced funding round or S-1 filing that resets the stale 2021 valuation

The call

The claims and licensure setup keeps carriers and AI startups out, but a merged rival with 20x the members and a five-year-old valuation leave the equity story unresolved.

Collective Health helps employers and workers navigate health insurance and claims by processing billions in claims annually and connecting to 200+ insurance systems, plus guiding people to the right doctors and care. Big insurance companies like UnitedHealth and Cigna cannot credibly copy this because they own insurance plans themselves, so offering truly neutral advice would hurt their own profits, a conflict that keeps them blocked. The real threat is Transcarent and Accolade merging into a much larger competitor with 20 million members versus Collective's 800,000, combined with Collective's valuation stuck at $1.5 billion from 2021 with no new funding round to prove the company has grown in value since then. The one thing that could change everything is whether Collective gets bought by a strategic buyer or forced into a distressed sale that wipes out common shareholders.

Why

Bigger players: Transcarent-Accolade (merged April 2025). Merged rival now claims 20 million-plus members versus Collective's 800,000, competing directly for the same employer RFPs. Could a giant copy it? Probably.

What would change this call

Collective Health announces a fresh priced funding round. Up-round shows growth intact; down-round shows investor doubt after 5 years stale at $1.5B.
A named enterprise client switches from Collective Health to Transcarent-Accolade. Would confirm direct customer loss to the merged peer rather than to insurers.
Collective Health files an S-1 or announces IPO plans. Would resolve valuation opacity and clarify true revenue scale among conflicting estimates.

Key numbers

800,000+ members across 50 states (2026-04-08)
$25 billion in cumulative medical claims processed (2026-04-08)
Last priced round: $280M Series F at $1.5B valuation (2021-05-04)

Named risks

Valuation stale since May 2021 Series F, no priced round for 5+ years risking down-round on next raise. Severity: high
Subscale versus merged Transcarent-Accolade, 800K vs 20M+ members as of April 2025. Severity: high
Publicly available revenue figures diverge widely across trackers, obscuring true financial health. Severity: medium
No confirmed IPO path despite unconfirmed 'IPO mentioned' chatter, leaving liquidity for equity holders unresolved. Severity: medium
AI-native chat and navigation entrants could commoditize the front-door member experience over time. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Transcarent-Accolade	losing to	Merged April 2025 to 20M+ members vs Collective Health's 800K as of April 2026
Included Health	contesting	Competes for large self-funded employer navigation contracts alongside Collective Health
Yuzu Health	contesting	AI-native TPA founded 2022, raised $5M seed 2023, targets same self-funded employer book
UnitedHealth/Optum, Cigna/Evernorth, Anthem/Elevance	contesting	Carrier incumbents structurally blocked from independent navigation by neutrality conflict

Questions people ask

Is Collective Health profitable in 2026?: Collective Health does not publicly disclose audited revenue or profit figures. It remains privately held and has not raised a new priced funding round since its $280M Series F in May 2021, leaving its financial health unverified as of 2026.
Is Collective Health a safe company to join right now?: Collective Health has real product lock-in via 200+ EDI integrations and $25B in processed claims (as of April 2026), but its $1.5B valuation dates to May 2021 with no fresh round since, and it now trails merged rival Transcarent-Accolade's 20M+ members versus its own 800,000.
Who is Collective Health's biggest competitor?: Transcarent completed its merger with Accolade in April 2025, creating a combined entity with 20M+ members and 1,700+ clients, dwarfing Collective Health's 800,000 members reported as of April 2026, making it the primary consolidation threat in benefits navigation.
Has Collective Health had layoffs?: Yes. In February 2023, CEO Ali Diab announced a layoff of 54 employees. No further Collective Health-specific layoffs have been publicly reported since, and headcount has since grown toward 750 to 800 employees per trackers.
What is Collective Health worth and who funds it?: Collective Health was valued at approximately $1.5 billion after its $280M Series F in May 2021, led by Health Care Service Corporation with DFJ Growth, Founders Fund, and SoftBank Vision Fund participating. No new priced round has been reported since.
How many members does Collective Health serve compared to rivals?: Collective Health reports 800,000+ members across 50 states as of April 2026, up from 300,000 in 2021, but rival Transcarent-Accolade reached 20M+ members after their April 2025 merger, a scale gap of roughly 25x.

Timeline

2026-04-01Hired new Chief Revenue Officer Kaushik Bhaumik, PhD
2026-02-24Launched Collective AI (CAI) via Google Cloud collaboration for member and advocate workflows
2025-04-08Transcarent completed merger with Accolade, reaching 20M+ members
2025-03-25Partnered with Noom Health to launch GLP-1 weight management benefit
2023-02-17CEO Ali Diab announced layoff of 54 employees
2022-01HCSC partnership began offering platform to self-funded members
2021-05-04Closed $280M Series F at approximately $1.5B post-money valuation

Revision history

29 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

American Airlines Group Wayfair Safe Superintelligence Inc.